On ECHEMI
Home > Drugs > Acute sinusitis
Acute sinusitis
Acute suppurative sinusitis is an acute suppurative inflammation of the sinus mucosa, which can affect the bones in severe cases. The maxillary sinus cavity is larger, the sinus floor is lower, and the sinus ostium is higher, which is easy to accumulate pus. It is located below the sinuses and is easily infected by inflammation in other places. Therefore, the incidence of maxillary sinusitis is the highest, followed by ethmoid sinusitis, frontal sinusitis, and sphenoid sinusitis.
  • Site of disease:

    nose
  • Infectious :

    Not contagious
  • Frequent population:

    More common in the young, elderly and frail
  • Related symptoms:

    Paroxysmal nasal congestion Increased nasal discharge and difficulty in blowing out Enlarged adenoids Intermittent nasal obstruction Nasal discharge with foul odor
  • Concurrent disease:

Related Drugs
Gatifloxacin Capsules
Indication: This product is mainly used for various infectious diseases caused by sensitive pathogens, including acute exacerbation of chronic bronchitis, acute sinusitis, community-acquired pneumonia, simple urinary tract infection (cystitis) and complicated urinary tract infection, acute pyelonephritis, male gonococcal urinary tract inflammation or rectal infection and female gonococcal cervical infection.
Manufacturer:

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Gatifloxacin Capsules
Indication: This product is mainly used for various infectious diseases caused by sensitive pathogens, including acute exacerbation of chronic bronchitis, acute sinusitis, community-acquired pneumonia, simple urinary tract infection (cystitis) and complicated urinary tract infection, acute pyelonephritis, male gonococcal urinary tract inflammation or rectal infection and female gonococcal cervical infection.
Manufacturer:

YANGTZE River Pharmaceutical Group Shanghai HAI-NI Pharmaceutical Co., Ltd.

Gatifloxacin Capsules
Indication: This product is mainly used for various infectious diseases caused by sensitive pathogens, including acute exacerbation of chronic bronchitis, acute sinusitis, community-acquired pneumonia, simple urinary tract infection (cystitis) and complicated urinary tract infection, acute pyelonephritis, male gonococcal urinary tract inflammation or rectal infection and female gonococcal cervical infection.
Manufacturer:

Jumpcan Pharmaceutical Group Co., Ltd.

Gatifloxacin and Glucose Injection
Indication: 1. For the treatment of acute exacerbation of chronic bronchitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus; 2. For the treatment of acute sinusitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, etc.; 3. For the treatment of community-acquired pneumonia of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila, or Legionella pneumophila; 4. For the treatment of simple or complicated urinary tract infection (cystitis) of moderate or above severity caused by sensitive strains: caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc.;
Manufacturer:

Hunan Jinjian Pharmaceutical Co., Ltd.

Gatifloxacin and Glucose Injection
Indication: 1. For the treatment of acute exacerbation of chronic bronchitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus; 2. For the treatment of acute sinusitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, etc.; 3. For the treatment of community-acquired pneumonia of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila, or Legionella pneumophila; 4. For the treatment of simple or complicated urinary tract infection (cystitis) of moderate or above severity caused by sensitive strains: caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc.;
Gatifloxacin and Glucose Injection
Indication: 1. For the treatment of acute exacerbation of chronic bronchitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus; 2. For the treatment of acute sinusitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, etc.; 3. For the treatment of community-acquired pneumonia of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila, or Legionella pneumophila; 4. For the treatment of simple or complicated urinary tract infection (cystitis) of moderate or above severity caused by sensitive strains: caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc.;
Gatifloxacin and Glucose Injection
Indication: 1. For the treatment of acute exacerbation of chronic bronchitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus; 2. For the treatment of acute sinusitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, etc.; 3. For the treatment of community-acquired pneumonia of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila, or Legionella pneumophila; 4. For the treatment of simple or complicated urinary tract infection (cystitis) of moderate or above severity caused by sensitive strains: caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc.;
Manufacturer:

Nanjing Sanhome Pharmaceutical Co., Ltd.

Gatifloxacin and Glucose Injection
Indication: 1. For the treatment of acute exacerbation of chronic bronchitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus; 2. For the treatment of acute sinusitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, etc.; 3. For the treatment of community-acquired pneumonia of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila, or Legionella pneumophila; 4. For the treatment of simple or complicated urinary tract infection (cystitis) of moderate or above severity caused by sensitive strains: caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc.;
Manufacturer:

Lanxiha Sanlian Pharmaceutical Co., Ltd.

Gatifloxacin and Glucose Injection
Indication: 1. For the treatment of acute exacerbation of chronic bronchitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus; 2. For the treatment of acute sinusitis of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, etc.; 3. For the treatment of community-acquired pneumonia of moderate or above severity caused by sensitive strains: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila, or Legionella pneumophila; 4. For the treatment of simple or complicated urinary tract infection (cystitis) of moderate or above severity caused by sensitive strains: caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc.;
Manufacturer:

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

Gatifloxacin Mesylate and Glucose Injection
Indication: Used to treat the following infectious diseases with a degree of infection or above caused by sensitive strains: Acute exacerbation of chronic bronchitis: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis or Staphylococcus aureus. Acute sinusitis: caused by Streptococcus pneumoniae, Haemophilus influenzae, etc. Community-acquired pneumonia: caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Staphylococcus aureus, Chlamydia pneumophila, Mycoplasma pneumophila or Legionella pneumophila, etc. Simple or complicated urinary tract infection (cystitis): caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, etc. Pelvic nephritis: caused by Escherichia coli, etc. Simple urethral and cervical gonorrhea: caused by Neisseria gonorrhoeae. Acute simple straight
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.